Pardes Biosciences Stock Total Asset
Pardes Biosciences fundamentals help investors to digest information that contributes to Pardes Biosciences' financial success or failures. It also enables traders to predict the movement of Pardes Stock. The fundamental analysis module provides a way to measure Pardes Biosciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Pardes Biosciences stock.
Pardes |
Pardes Biosciences Company Total Asset Analysis
Pardes Biosciences' Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Current Pardes Biosciences Total Asset | 200.62 M |
Most of Pardes Biosciences' fundamental indicators, such as Total Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pardes Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
CompetitionBased on the latest financial disclosure, Pardes Biosciences has a Total Asset of 200.62 M. This is 97.33% lower than that of the Biotechnology sector and 89.85% lower than that of the Health Care industry. The total asset for all United States stocks is 99.32% higher than that of the company.
Pardes Total Asset Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pardes Biosciences' direct or indirect competition against its Total Asset to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pardes Biosciences could also be used in its relative valuation, which is a method of valuing Pardes Biosciences by comparing valuation metrics of similar companies.Pardes Biosciences is currently under evaluation in total asset category among its peers.
Pardes Fundamentals
Return On Equity | -0.4 | |||
Return On Asset | -0.26 | |||
Current Valuation | (22.1 M) | |||
Shares Outstanding | 62.01 M | |||
Shares Owned By Insiders | 13.47 % | |||
Shares Owned By Institutions | 72.05 % | |||
Number Of Shares Shorted | 874.35 K | |||
Price To Book | 0.37 X | |||
EBITDA | (99.82 M) | |||
Net Income | (96.63 M) | |||
Cash And Equivalents | 228.6 M | |||
Cash Per Share | 3.67 X | |||
Current Ratio | 20.84 X | |||
Book Value Per Share | 2.57 X | |||
Cash Flow From Operations | (71.98 M) | |||
Short Ratio | 1.09 X | |||
Earnings Per Share | (1.28) X | |||
Target Price | 1.25 | |||
Number Of Employees | 57 | |||
Beta | 0.42 | |||
Market Capitalization | 133.95 M | |||
Total Asset | 200.62 M | |||
Retained Earnings | (148.16 M) | |||
Working Capital | 179.98 M | |||
Z Score | -1.6 | |||
Net Asset | 200.62 M |
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |